SCHEMBL7709177

SCHEMBL7709177

O=C(O)C12C3C4C1C1C2C3C41C(=O)CC1c2ccccc2Sc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 3/20 0.44
GRM5 P41594 2/20 0.44
CYP2D6 P10635 2/20 0.40
BCHE P06276 3/20 0.37
ACHE P22303 2/20 0.37
TSHR P16473 2/20 0.33
EGFR P00533 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD1 P21728 1/20 0.33
TBXA2R P21731 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664795 0.77 GRM1 (0.49) GRM1GRM5CYP2D6BCHEACHE
SCHEMBL7711872 0.76 GRM1 (0.53) GRM1GRM5CYP2D6BCHEACHE
SCHEMBL7711972 0.72 GRM5 (0.36) GRM1GRM5CYP2D6CYP2C19
SCHEMBL8340352 0.69 GRM5 (0.34) GRM1GRM5CYP2D6BCHETSHR
SCHEMBL28754501 0.69 GRM1 (0.42) GRM1GRM5CYP2D6BCHEACHE
SCHEMBL11055807 0.68 GRM5 (0.53) GRM1GRM5CYP2D6LMNA
SCHEMBL5756547 0.64 GRM1 (0.51) GRM1GRM5CYP2D6BCHEACHE
SCHEMBL751446 0.63 GRM1 (0.50) GRM1GRM5CYP2D6BCHEACHE
SCHEMBL16617866 0.63 CYP2D6 (0.56) GRM1GRM5CYP2D6BCHEACHE
SCHEMBL8386890 0.63 MAPK1 (0.41) GRM1GRM5CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6784202-B1 EXEMPLIFIED BY 4-CARBOXYCUBANE-1-THIOXANTHYL L-GLYCINE FOR TREATMENT OF PSYCHIATRIC AND NERVOUS SYSTEM DISORDERS PRESCIENT NEUROPHARMA INC. (CA) 2004-08-31 US disclosed